Değer202020212022202320242025Toplam yükümlülükler——————Toplam özsermaye——————Toplam yükümlülükler ve hissedarların özsermayesi——————Toplam borç——————Net borç——————
ProQR Therapeutics N.V. - Ordinary Shares
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.